• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Economy

Trump bans federal funding for ‘dangerous’ gain-of-function research

by May 6, 2025
by May 6, 2025

President Donald Trump signed an executive order on Monday banning all federal funding for ‘dangerous’ gain-of-function research in China, Iran and other countries and blocking all federal funding for foreign research that could cause another pandemic. 

The president signed the order Monday afternoon to improve the safety and security of biological research in the U.S. and around the world. 

The White House said the order ‘will drastically reduce the potential for lab-related incidents involving gain-of-function research, like that conducted on bat coronaviruses in China by the EcoHealth Alliance and Wuhan Institute of Virology.’ 

Gain-of-function research typically involves modifying a virus to make it more infectious among humans. Gain of function research took place at the Wuhan Lab before the COVID-19 pandemic began. 

The White House said the order will protect Americans from lab accidents and other biosecurity incidents, ‘such as those that likely caused COVID-19 and the 1977 Russian flu.’ 

The president’s order ends any present and all future federal funding of gain-of-function research in countries with insufficient oversight of research, and it empowers U.S. research agencies to identify and end federal funding of any other biological research that could pose a threat to American public health, public safety or national security. 

‘For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight,’ the White House said in a fact sheet describing the order. ‘Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.’ 

The order, according to the White House, ‘protects Americans from dangerous gain-of-function research that manipulates viruses and other biological agents and toxins, but it does not impede productive biological research that will ensure the United States maintains readiness against biological threats and continues to drive global leadership in biotechnology, biosecurity, and health research.’ 

‘President Trump has long theorized that COVID-19 originated from a lab leak at the Wuhan Institute of Virology and has consistently pushed for transparency in investigating its origins,’ the White House said. 

This is a developing story. Please check back for updates. 

This post appeared first on FOX NEWS

0 comment
0
FacebookTwitterPinterestEmail

previous post
Israel strikes Yemen’s port city in response to Houthi attack on Tel Aviv Airport
next post
Trump-aligned group sues Chief Justice John Roberts in effort to restrict power of the courts

Related Posts

The Fed Sees Higher Inflation Coming — and...

March 23, 2026

California’s Water Crisis Isn’t a Drought—It’s Bad Policy

March 23, 2026

Silent Cal’s Loud Lesson on Tax Cuts

March 23, 2026

Adam Smith’s Three Steps to Prosperity

March 23, 2026

Bigger Isn’t Better: A Case for Downsizing the...

March 20, 2026

What 122 Universal Basic Income Experiments Actually Show

March 20, 2026

Interest Rate Caps Keep Coming Back — Bastiat...

March 19, 2026

Congress Knows It Has a Spending Problem, But...

March 19, 2026

Free Speech in the Digital Age: From Natural...

March 18, 2026

Reflections on Saturday Morning TV—and The Regulations That...

March 18, 2026

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • Michael Saylor’s Strategy (MSTR) buys 1,031 Bitcoin, slows pace of BTC buys

    March 23, 2026
  • Apple stock surges as iPhone demand, Mac sales lift outlook

    March 23, 2026
  • Carnival share price analysis: extremely pressured ahead of earnings

    March 23, 2026
  • AeroVironment stock price sinks as risky patterns emerge: can it hit $170?

    March 23, 2026
  • Is Elliott’s stake in Synopsys stock your cue to buy?

    March 23, 2026
  • Nvidia stock rebounds around 3%: what’s behind the rally?

    March 23, 2026

Editors’ Picks

  • 1

    Pop Mart reports 188% profit surge, plans aggressive global expansion

    March 26, 2025
  • 2

    New FBI leader Kash Patel tapped to run ATF as acting director

    February 23, 2025
  • 3

    Meta executives eligible for 200% salary bonus under new pay structure

    February 21, 2025
  • 4

    Anthropic’s newly released Claude 3.7 Sonnet can ‘think’ as long as the user wants before giving an answer

    February 25, 2025
  • 5

    Walmart earnings preview: What to expect before Thursday’s opening bell

    February 20, 2025
  • ‘The Value of Others’ Isn’t Especially Valuable

    April 17, 2025
  • 7

    Cramer reveals a sub-sector of technology that can withstand Trump tariffs

    March 1, 2025

Categories

  • Economy (4,458)
  • Editor's Pick (570)
  • Investing (901)
  • Stock (2,848)
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Read alsox

Jeanine Pirro sworn in as interim US...

May 29, 2025

Tariff Tension: Will US Shelves Be Empty...

May 6, 2025

IOUs to Inflation: The Realistic Limits of...

July 31, 2025